These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 4263510)

  • 21. Synergystic action of sera from transplant recipients and lymphocytes activated in vitro.
    Gordon J; MacDonald H; MacLean LD
    Transplant Proc; 1973 Mar; 5(1):429-31. PubMed ID: 4695951
    [No Abstract]   [Full Text] [Related]  

  • 22. Sarcoidosis: correlation of delayed hypersensitivity, MLC reactivity and lymphocytotoxicity with disease activity.
    Broom BC; MacLaurin BP
    Clin Exp Immunol; 1973 Nov; 15(3):355-64. PubMed ID: 4271772
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of in vitro lymphocyte blastogenesis by inhibitor produced by cultured human lymphoblasts.
    Hersh EM; McCredie KB; Freireich EJ
    Clin Exp Immunol; 1974 Jul; 17(3):463-73. PubMed ID: 4283280
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte activation and destruction in vitro in relation to MLC and HL-A.
    Eijsvoogel VP; du Bois R; Melief CJ; Zeylemaker WP; Raat-Koning L; de Groot-Kooy L
    Transplant Proc; 1973 Sep; 5(3):1301-7. PubMed ID: 4125685
    [No Abstract]   [Full Text] [Related]  

  • 25. Cytotoxic effects of activated lymphocytes and their supernatants.
    Holm G; Stejskal V; Perlmann P
    Clin Exp Immunol; 1973 Jun; 14(2):169-79. PubMed ID: 4717912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytotoxicity of human lymphocytes induced by pokeweed mitogen or in mixed lymphocyte culture. Specificity and nature of effector cells.
    Stejskal V; Härfast B; Holm G; Perlmann P
    Eur J Immunol; 1974 Feb; 4(2):126-30. PubMed ID: 4277425
    [No Abstract]   [Full Text] [Related]  

  • 27. Cell-mediated lympholysis in dogs: studies of the cytotoxic mechanism.
    Flad HD; Goldmann SF; Krumbacher K; Schnappauf H; Huget RP
    Transplant Proc; 1975 Sep; 7(3):407-10. PubMed ID: 51525
    [No Abstract]   [Full Text] [Related]  

  • 28. Cell mediated lympholysis in man. The impact of SD determinants on in vitro induced lympholysis.
    Grunnet N; Kristensen T; Jorgensen F; Kissmeyer-Nielsen F
    Tissue Antigens; 1974; 4(3):218-28. PubMed ID: 4277393
    [No Abstract]   [Full Text] [Related]  

  • 29. Ontogeny of mouse lymphocyte function. I. Paradoxical elevation of reactivity to allogeneic cells and phytohemagglutinin in BALB-c fetal thymocytes.
    Mosier DE
    J Immunol; 1974 Jan; 112(1):305-10. PubMed ID: 4272922
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lymphocyte interaction in presence of phytohemagglutinin. A new possibility for the analysis of manifestations of histo-incompatibility in vitro].
    Tridente G; Mok G; Lupatin-Tridente E; Fiore-Donati L
    Haematologica; 1972; 58(9):560-4. PubMed ID: 4274096
    [No Abstract]   [Full Text] [Related]  

  • 31. Membrane properties and functional activity of lymphocytes from cyclophosphamide-pretreated rats.
    Guttmann RD
    J Immunol; 1974 Apr; 112(4):1594-601. PubMed ID: 4273628
    [No Abstract]   [Full Text] [Related]  

  • 32. Virus plaque assay and enumeration of effector cells in mixed lymphocyte cultures.
    Bloom BR; Kano S; Howe ML
    Transplant Proc; 1973 Dec; 5(4):1705-9. PubMed ID: 4359723
    [No Abstract]   [Full Text] [Related]  

  • 33. Serotyping for MLC gene products. II. ABCIL detection of HLA-D specificities by the "tandem" technique, using multiparous sera before and after absorption with HLA-D homozygous lymphocytes.
    Kovithavongs T; Marchuk L; Schlaut J; Dossetor JB
    Transplant Proc; 1977 Mar; 9(1):445-9. PubMed ID: 141131
    [No Abstract]   [Full Text] [Related]  

  • 34. Antibody-dependent lymphocyte killer function and age.
    McConnachie PR; Rachelefsky G; Stiehm ER; Terasaki PI
    Pediatrics; 1973 Dec; 52(6):795-800. PubMed ID: 4272165
    [No Abstract]   [Full Text] [Related]  

  • 35. Lymphocyte inhibition by mammary tumor virus in patients with breast cancer.
    Moulton A; Gerfo PL; Suciu-Foca N; Silverstein G
    J Surg Res; 1974 Jun; 16(6):592-8. PubMed ID: 4366357
    [No Abstract]   [Full Text] [Related]  

  • 36. [Applications of transplantation immunology in medicine].
    Hamburger J
    Nouv Presse Med; 1973 Jan; 2(1):11-4 contd. PubMed ID: 4265310
    [No Abstract]   [Full Text] [Related]  

  • 37. MLC and CMC reactivity and specificity of idiotype-specific lymphoid cells enriched for histocompatibility (H-2) antigens.
    Folks TM; Ahmed A; Ryan JJ; Feldmann M; Woody J; Sell KW
    Transplant Proc; 1979 Mar; 11(1):683-9. PubMed ID: 88095
    [No Abstract]   [Full Text] [Related]  

  • 38. Lymphocyte-mediated tumor cell destruction in vitro. Some general principles and reactivities in human urinary bladder carcinoma.
    Perlmann P; O'Toole C; Unsgaard B
    Natl Cancer Inst Monogr; 1972 Dec; 35():223-9. PubMed ID: 4540587
    [No Abstract]   [Full Text] [Related]  

  • 39. Immunologic monitoring of the transplant recipient.
    Stiller CR; Dossetor JB; Carpenter CB; Myburgh JA
    Transplant Proc; 1977 Mar; 9(1):1245-54. PubMed ID: 141124
    [No Abstract]   [Full Text] [Related]  

  • 40. Abrogation of cytotoxicity of mixed leukocyte cultures.
    Bach ML; Alter BJ; Lightbody JJ; Bach FH
    Transplant Proc; 1972 Jun; 4(2):169-72. PubMed ID: 5034145
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.